Fjarde Ap-fonden’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $39.9M | Sell |
103,122
-2,920
| -3% | -$1.08M | 0.19% | 102 |
|
|
2026
Q1 | $31M | Buy |
106,042
+37,090
| +54% | +$12.2M | 0.17% | 120 |
|
|
2025
Q4 | $24.2M | Sell |
68,952
-9,260
| -12% | -$3.13M | 0.2% | 99 |
|
|
2025
Q3 | $25.3M | Sell |
78,212
-3,000
| -4% | -$933K | 0.22% | 96 |
|
|
2025
Q2 | $31.6M | Buy |
81,212
+34,500
| +74% | +$13.9M | 0.29% | 72 |
|
|
2025
Q1 | $20.3M | Sell |
46,712
-3,200
| -6% | -$1.28M | 0.24% | 87 |
|
|
2024
Q4 | $18.4M | Sell |
49,912
-2,800
| -5% | -$1.17M | 0.19% | 102 |
|
|
2024
Q3 | $27.4M | Buy |
+52,712
| New | +$28.2M | 0.28% | 69 |
|
|
2024
Q1 | $25.3M | Buy |
48,712
+3,400
| +8% | +$1.69M | 0.28% | 75 |
|
|
2023
Q4 | $21.4M | Buy |
45,312
+1,100
| +2% | +$509K | 0.27% | 79 |
|
|
2023
Q3 | $19.3M | Sell |
44,212
-500
| -1% | -$227K | 0.26% | 78 |
|
|
2023
Q2 | $19.9M | Sell |
44,712
-1,700
| -4% | -$784K | 0.24% | 80 |
|
|
2023
Q1 | $21.3M | Sell |
46,412
-150
| -0.3% | -$71.4K | 0.29% | 73 |
|
|
2022
Q4 | $23.9M | Sell |
46,562
-600
| -1% | -$305K | 0.34% | 61 |
|
|
2022
Q3 | $22.8M | Hold |
47,162
| – | – | 0.29% | 69 |
|
|
2022
Q2 | $22.8M | Sell |
47,162
-17,800
| -27% | -$8.81M | 0.29% | 69 |
|
|
2022
Q1 | $31.9M | Buy |
64,962
+2,000
| +3% | +$914K | 0.31% | 62 |
|
|
2021
Q4 | $29.2M | Sell |
62,962
-4,348
| -6% | -$1.83M | 0.26% | 79 |
|
|
2021
Q3 | $25.1M | Sell |
67,310
-300
| -0.4% | -$114K | 0.23% | 88 |
|
|
2021
Q2 | $25.8M | Sell |
67,610
-4,900
| -7% | -$1.87M | 0.24% | 87 |
|
|
2021
Q1 | $26M | Sell |
72,510
-500
| -0.7% | -$161K | 0.24% | 88 |
|
|
2020
Q4 | $23.4M | Sell |
73,010
-2,700
| -4% | -$829K | 0.22% | 90 |
|
|
2020
Q3 | $20.3M | Sell |
75,710
-100
| -0.1% | -$26.9K | 0.22% | 88 |
|
|
2020
Q2 | $19.9M | Buy |
75,810
+6,600
| +10% | +$1.76M | 0.25% | 78 |
|
|
2020
Q1 | $15.7M | Sell |
69,210
-3,800
| -5% | -$1.04M | 0.25% | 83 |
|
|
2019
Q4 | $22.1M | Sell |
73,010
-1,400
| -2% | -$385K | 0.27% | 73 |
|
|
2019
Q3 | $17.9M | Sell |
74,410
-4,091
| -5% | -$1.12M | 0.23% | 94 |
|
|
2019
Q2 | $22.2M | Buy |
78,501
+200
| +0.3% | +$54.6K | 0.28% | 72 |
|
|
2019
Q1 | $22.5M | Buy |
78,301
+16,351
| +26% | +$4.73M | 0.28% | 70 |
|
|
2018
Q4 | $16.3M | Sell |
61,950
-6,200
| -9% | -$1.7M | 0.28% | 72 |
|
|
2018
Q3 | $18.7M | Sell |
68,150
-3,603
| -5% | -$935K | 0.28% | 77 |
|
|
2018
Q2 | $17.1M | Sell |
71,753
-1,565
| -2% | -$362K | 0.26% | 79 |
|
|
2018
Q1 | $16.1M | Sell |
73,318
-866
| -1% | -$203K | 0.25% | 87 |
|
|
2017
Q4 | $16.7M | Buy |
74,184
+10,544
| +17% | +$2.25M | 0.25% | 85 |
|
|
2017
Q3 | $12.1M | Buy |
63,640
+996
| +2% | +$190K | 0.23% | 97 |
|
|
2017
Q2 | $11.8M | Buy |
62,644
+9,254
| +17% | +$1.66M | 0.24% | 95 |
|
|
2017
Q1 | $8.83M | Sell |
53,390
-3,770
| -7% | -$600K | 0.21% | 108 |
|
|
2016
Q4 | $8.22M | Sell |
57,160
-5,662
| -9% | -$758K | 0.19% | 121 |
|
|
2016
Q3 | $7.87M | Buy |
62,822
+2,030
| +3% | +$262K | 0.17% | 131 |
|
|
2016
Q2 | $7.98M | Buy |
60,792
+875
| +1% | +$120K | 0.19% | 119 |
|
|
2016
Q1 | $8.33M | Buy |
59,917
+7,300
| +14% | +$976K | 0.19% | 118 |
|
|
2015
Q4 | $7.34M | Sell |
52,617
-263
| -0.5% | -$36.2K | 0.19% | 119 |
|
|
2015
Q3 | $7.4M | Sell |
52,880
-4,158
| -7% | -$625K | 0.21% | 111 |
|
|
2015
Q2 | $9.36M | Sell |
57,038
-3,707
| -6% | -$592K | 0.23% | 100 |
|
|
2015
Q1 | $9.38M | Sell |
60,745
-5,169
| -8% | -$736K | 0.22% | 103 |
|
|
2014
Q4 | $8.28M | Sell |
65,914
-5,051
| -7% | -$624K | 0.18% | 126 |
|
|
2014
Q3 | $8.49M | Sell |
70,965
-6,201
| -8% | -$711K | 0.18% | 125 |
|
|
2014
Q2 | $8.3M | Sell |
77,166
-8,697
| -10% | -$896K | 0.17% | 142 |
|
|
2014
Q1 | $8.55M | Buy |
85,863
+3,036
| +4% | +$275K | 0.17% | 138 |
|
|
2013
Q4 | $7.65M | Sell |
82,827
-5,913
| -7% | -$525K | 0.16% | 142 |
|
|
2013
Q3 | $7.42M | Sell |
88,740
-7,077
| -7% | -$607K | 0.16% | 137 |
|
|
2013
Q2 | $7.84M | Buy |
+95,817
| New | +$7.17M | 0.16% | 134 |
|
Other funds holding ELV
Fjarde Ap-fonden's ELV Position: Q2 2026 in Review
Fjarde Ap-fonden reduced its Elevance Health (ELV) stake by 2.8% in Q2 2026, selling an estimated $1.08M and leaving 103,122 shares worth $39.9M. The position accounts for 0.19% of the portfolio, ranked #102.
Fjarde Ap-fonden first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Fjarde Ap-fonden held 103,122 shares of Elevance Health worth $39.9M as of Q2 2026.
- Fjarde Ap-fonden sold 2,920 Elevance Health shares in Q2 2026, an estimated $1.08M.
- Elevance Health made up 0.19% of Fjarde Ap-fonden's portfolio in Q2 2026, its #102 holding.
- Fjarde Ap-fonden first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Fjarde Ap-fonden's 13F filing for Q2 2026, filed 29 Jul 2026.